European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 1997
Visceral leishmaniasis in patients infected with the human immunodeficiency virus.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Laguna F, Adrados M, Alvar J, Soriano V, Valencia M E, Moreno V, Polo R, Verdejo J, Jiménez M I, Martínez P, Martínez M L, González-Lahoz J M
Аннотация
The experience with 52 episodes of visceral leishmaniasis diagnosed in 43 patients is reported. The most common symptoms were fever (81%), splenomegaly (65%), hepatomegaly (63%), and pancytopenia (73%). In 79% of the patients, CD4+ cell counts were < 100 cells/mm3. Prior or simultaneous diagnosis of AIDS was made in 29 (67%) patients. Diagnosis was considered fortuitous in 19% of the episodes. In 27% of the episodes, the diagnosis was made on the basis of demonstration of parasites outside the reticuloendothelial system, chiefly blood (7 cases) and gastrointestinal mucosa (5 cases). Parasites were frequently observed or cultured from blood (22/37 episodes) or the digestive tract (8/9 episodes). High antimony doses were more effective than low doses in achieving clinical or parasitological cure (rate of cure, 80% vs. 40%, p = 0.11). Severe toxicity was observed in six (11.7%) of the 51 treated episodes. Severe AIDS-related diseases [odds ratio (OR) 10, p < 0.05] and CD4+ counts (OR 12, p < 0.05) were independent factors for early death. Prophylaxis with monthly pentamidine was not useful in reducing relapses of visceral leishmaniasis.
Предметные рубрики MeSH
AIDS-Related Opportunistic InfectionsAllopurinolAmebicidesAmphotericin BAnalysis of VarianceAnti-HIV AgentsAntimetabolitesAntimonyAntiprotozoal AgentsBloodBone MarrowCD4-Positive T-LymphocytesCerebrospinal FluidDidanosineDigestive SystemDose-Response Relationship, DrugDrug Therapy, CombinationFemaleFollow-Up StudiesHIVHepatic EncephalopathyHumansIntestinal MucosaLeishmaniasis, VisceralLymphocyte CountMaleMyocarditisNeutrophilsPancreatitisPentamidineRenal InsufficiencySpainZidovudine